Medicis to acquire LipoSonix
Medicis and LipoSonix, Inc. jointly announced they have entered into a definitive merger agreement under which Medicis will acquire LipoSonix, an independent, privately-held company with a staff of approximately 40 scientists, engineers and clinicians located near Seattle, Washington.
The best selling drug in the country, Lipitor, is now available in generic form.